China-Israel Summit on Innovative Diagnostic Tools for Precision Medicine in Aging Populations Held as Planned
With the rapid development of China’s healthcare sector and the accelerated pace of medical system reforms, the market prospects for China’s healthcare industry are exceptionally broad. Leveraging a potential consumer base of 1.4 billion people, substantial market opportunities, and a surge in emerging talent, the Chinese healthcare market has become a key focus for continued investment by the world’s largest healthcare companies. Experts predict that the market size of China’s biopharmaceutical industry will exceed RMB 4 trillion in 2022.
The coming years will present a critical window of opportunity for the development of China’s innovation-driven economy. Science and technology enterprises must strive to alleviate the current pressures on the healthcare system, gradually replacing or serving as a robust complement to major health and medical suppliers. Beijing Pinqi and the Qingdao Israel International Living Room will focus their collaboration on precision medicine for the middle-aged and elderly population, targeting this specialized niche. By leveraging technical tools such as human genome sequencing, biomedical analysis, and big data analytics—augmented by cutting-edge technologies including artificial intelligence, VR/AR, cloud computing, and wearable devices—they will achieve deep integration with healthcare services. This approach aims to enable accurate, individualized decision-making and the precise application of diagnostic and treatment protocols, thereby delivering an optimized health management framework.
On October 20, 2021, Beijing Pinqi and the Qingdao Israel International Living Room jointly hosted the Qingdao International Health Technology Forum, officially kicking off the First Summit on Innovative Diagnostic Tools for Middle-Aged and Elderly Health in Qingdao.
Beijing Pinqi has deeply cultivated the big health sector, leveraging resource support from leading enterprises in the tech-internet and medical industries, with a commitment to creating the most valuable spaces. Its subsidiary, Houkang International Smart Technology Center, is based in Qingdao and serves as a modern hub for advanced medical services radiating across the Shandong Peninsula; its launch ceremony will be held on the day of the summit.
Pinqi Asset Management is an asset management platform focused on real estate in the broader health sector. Its brand, Houkang, serves as a leading integrated operator of health-related real estate, with product lines including Health Technology Centers, Medical Industrial Parks, and Urban Medical Malls. By leveraging smart park management systems and advanced technologies, it empowers the management of industrial parks; through industrial funds and resource integration, it builds a complete ecological chain.
Houkang International Health Technology Center serves as a hub for big health and technology enterprises. Leveraging the Tsinghua University Beijing Institute of Interdisciplinary Research on Traditional Chinese Medicine (Professor Li Shao’s Team) and the Domestic Medical Information Innovation Center at Zhejiang University Binjiang Research Institute, it has established itself as an R&D and commercialization base for the big health industry. Furthermore, by utilizing group resources, it organizes professional industry events for resident enterprises and aggregates industrial resources.
The Qingdao-Israel International Living Room is strategically positioned as a new highland for comprehensive innovation cooperation between China and Israel. It aims to match and complement Israeli innovation and entrepreneurship with China’s advantages in production capacity and market access, thereby establishing a comprehensive resource-matching platform for talent, technology, and capital from both countries.
The summit invited research experts and renowned entrepreneurs from the fields of traditional Chinese medicine R&D, healthcare funds, and medical technology. Under the theme “Silver Years, Fresh Perspectives,” participants engaged in keynote speeches and roundtable discussions to focus on and explore the development direction of precision medicine for middle-aged and elderly diseases, providing a comprehensive and in-depth interpretation of its sub-sectors, while also serving as a platform for medical technology exchange between China and Israel.
This summit will feature discussions and insights from multiple perspectives, including genetic technology, Traditional Chinese Medicine (TCM) diagnosis and treatment, healthcare real estate, and smart health communities, providing a multidimensional analysis of the development prospects for precision medicine. Zhu Shida, Vice President of BGI Group, will deliver an in-depth analysis of how genetic technology can support healthy aging. Zhang Jin, Dean of the Research Institute of China Health and Elderly Care Group, will focus on the emerging track of health and elderly care, sharing new perspectives for the "silver-haired" era. Israel’s Meuhedet Health Services will also share its experience in managing chronic pain and diseases within elderly communities. Zheng Yufen, Founder of Joy Capital Medical Fund, will offer strategies for capital integration for enterprises in the venture capital era, drawing on the current investment landscape in digital health within the broader healthcare sector. Meanwhile, Yan Honghui, Founder of Houbo Huici Medical, will propose an innovative service model combining "diagnosis and treatment + elderly care" for smart health communities, injecting new concepts into smart elderly care.
In recent years, as favorable policies for digital health have been successively introduced in various countries, technological innovation is accelerating the rapid global rise of digital health. Israel possesses advanced digital health technologies, particularly leading the way in telemedicine, wearable devices, AI-driven medical applications, and big data analytics in healthcare. The holding of this summit has promoted international medical exchange and cooperation between China and Israel, thereby supporting the development of the healthcare industry. The CEO of Israel’s TOP Experts Center stated that in-depth collaboration and comprehensive innovation are the ultimate goals of the “China-Israel” project focused on diagnosing diseases in middle-aged and elderly populations. By leveraging complementary advantages with Israel’s innovative industries, establishing a comprehensive platform for connecting technology, talent, and capital between the two countries, and utilizing cutting-edge technologies to empower various sub-sectors or break through traditional paradigms to seek new commercial breakthroughs, we can accelerate the pace of China’s future development in precision medicine and ultimately achieve a win-win outcome.
2021, as the inaugural year of the 14th Five-Year Plan, marks the beginning of a golden era for smart healthcare in China, driven by the continuous advancement of next-generation information technologies. In the future, the healthcare industry will integrate more high-tech innovations, such as artificial intelligence and sensor technologies, enabling medical services to achieve true intelligence. Information technology will complement digital medicine, establishing a more precise medical diagnosis system. Precision health and precision medicine will become the forefront of future healthcare, driving innovation across the entire health and medical industry.
The 1st Qingdao International Health Technology Forum focused on precision medicine for middle-aged and elderly populations, conducting specialized discussions across its subfields. It also provided a cross-border platform for medical technology exchange between China and Israel, offering deep, multi-dimensional, and vertically integrated insights. Beijing Pinqi, in collaboration with the Qingdao Israel International Living Room, aims to leverage this summit to build a platform for communication and interaction among stakeholders in related industries, jointly exploring future development trends in the field of precision medicine.
